Repository logo
 
Loading...
Thumbnail Image
Publication

Photodynamic therapy as adjunctive therapy for morpheaform basal cell carcinoma

Use this identifier to reference this record.

Advisor(s)

Abstract(s)

The authors decided to evaluate the possible use of methyl-aminolevulinate photodynamic therapy (MAL-PDT) as adjunctive therapy for morpheaform basal cell carcinoma prior to standard surgical excision in order to reduce tumor size and volume and to facilitate surgical treatment. It was observed that MAL-PDT may be an option as an adjunctive therapy prior to standard surgical excision of morpheaform basal cell carcinoma, leading to less invasive surgery

Description

Keywords

photodynamic therapy morpheaform basal cell carcinoma adjunctive therapy

Citation

Acta Dermatovenerol Alp Panonica Adriat. 2011;20(1):23-5.

Research Projects

Organizational Units

Journal Issue